InvestorsHub Logo
Followers 7
Posts 687
Boards Moderated 0
Alias Born 06/11/2018

Re: None

Friday, 04/26/2019 3:32:20 PM

Friday, April 26, 2019 3:32:20 PM

Post# of 394
View this email in your browser?


PreveCeutical's Chief Research Officer, Dr. Harry Parekh joined Steve Darling from Proactive Investors in Vancouver. They discussed the companies progress in the development of their sustained-release, cannabis and CBD-based nose-to-brain delivery system, Sol-gel.


You can view the video at

 

For further information, please contact:

PreveCeutical:

Deanna Kress
Director of Corporate Communications & Investor Relations
deanna@PreveCeutical.com

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRVCF News